JADA LOVICK: Open Payments
NPI 1265278329 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$835 in 27 payments from 11 companies in 2025. Trend: 2023 $23 · 2024 $450 · 2025 $835
Food & beverage: $736Education: $99
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $271 |
| Indivior Inc. | 7 | $213 |
| Novo Nordisk Inc | 4 | $92 |
| Collegium Pharmaceutical, Inc. | 3 | $56 |
| Alkermes, Inc. | 2 | $47 |
| ABBVIE INC. | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $34 |
| Astellas Pharma US Inc | 1 | $23 |
| Braeburn Inc. | 1 | $22 |
| Boston Scientific Corporation | 1 | $22 |
Products named: SUBLOCADE, AUSTEDO XR, Jornay PM, Wegovy, VIVITROL, VRAYLAR, INGREZZA, Rybelsus.
Industry payments across MD — which companies pay providers there.
